G1 Therapeutics Inc
F:G1H
G1 Therapeutics Inc
F:G1H
Price:
6.345
EUR
Market Closed
Market Cap:
€331.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
G1 Therapeutics Inc
F:G1H
|
US |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
Tomra Systems ASA
F:TMR
|
NO |
|
C
|
Celanese Corp
SWB:DG3
|
US |
|
P
|
Paccar Inc
LSE:0KET
|
US |
|
P
|
Panin Financial Tbk PT
XMUN:OHH
|
ID |
|
A
|
argenx SE
F:1AE
|
NL |
|
S
|
Schlumberger NV
XBER:SCL
|
US |
|
F
|
Fuji Media Holdings Inc
SWB:FTN
|
JP |
|
Network-1 Technologies Inc
F:6LK
|
US |
|
S
|
Swiss Re AG
LSE:0QL6
|
CH |
|
Bollore SE
PAR:BOL
|
FR |
|
D
|
Discover Financial Services
DUS:DC7
|
US |
|
Ryman Healthcare Ltd
F:RH70
|
NZ |
|
Barclays PLC
LSE:BARC
|
UK |
|
S
|
Siemens Healthineers AG
XBER:SHL
|
DE |
|
T
|
Thomson Reuters Corp
NYSE:TRI
|
CA |
|
FIRST BANK (Hamilton)
F:6UT
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
C
|
China Petroleum & Chemical Corp
LSE:SNP
|
CN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G1H's stock price target?
Not Available
G1H does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for G1 Therapeutics Inc?
Projected CAGR
10%
10%
Over the last 8 years, the compound annual growth rate for Revenue has been 88%. The projected CAGR for the next 3 years is 10%.
